The need to reliably test the pH of a fluid sample is a requirement in a plethora of industries, particularly where the pH is indicative of potential quality, safety or health concerns. pH measurements are important in, for example, medicine, biology, chemistry, agriculture, forestry, food science, environmental science, oceanography, civil engineering, chemical engineering, nutrition, water treatment and water purification.
The pH of water is routinely tested. The pH of drinking water is routinely monitored to ensure that it is safe to drink, whereas the water in swimming pools is routinely tested to ensure that it is safe to swim in. Monitoring alterations in the pH of fish ponds or river water can be indicative of environmental pollution. In agriculture and horticulture, knowledge of the pH of the soil is not only instructive in the selection of suitable crops but also discerns whether there are local environmental issues, such as pollution. In the food and brewing industries, maintaining a proper pH range is essential in many of the physical and chemical reactions that take place during food and drink processing. Monitoring the pH of bodily fluids can be a useful diagnostic. For example, it has been demonstrated that the pH of saliva can predict susceptibility to a range of diseases, including cancer, heart disease and osteoporosis.
pH testing is conventionally performed using pH meters, but these are impractical for a variety of applications as they require regular calibration using standard buffer solutions. Furthermore, the glass electrodes are fragile and must be kept constantly wet, normally in an acidic solution, in order to avoid dehydration of the pH sensing membrane and subsequent dysfunction of the electrode. Disposable pH test strips are available, but due to the permanence of the colour change as a function of pH of the test sample, the strips are unable to demonstrate any changes in pH over time. Additionally, the disposable characteristic adds to the cost implications.
A need exists for a device which enables the real-time, reversible and stable detection of pH in a fluid.
This application discloses devices and methods related to devices having pH indicators for monitoring the pH of a fluid. Other advantages and improvements will be apparent to one of skill in the art upon review of the application.
In one aspect, a device is provided for determining pH of a fluid sample. The device preferably includes a surface configured to contact the fluid and a pH indicator covalently immobilised thereon, wherein the pH indicator has a first colour prior to contact with the fluid and changes colour along a colour spectrum as a function of the pH of the fluid. In embodiments, the pH indicator changes colour in response to change in pH and this colour change is detectable at, for example, intervals of about a 0.1 unit, about 0.2 unit, about 0.3 unit about 0.4 unit or about 0.5 unit interval of pH. It is envisaged that the detection level will vary based on the type of detection means utilised. For example, an electronic detector such as a colour meter capable of detecting changes in colour of light, has the capability to detect a 0.1 unit change in pH. In comparison, the human eye is only capable of visually detecting a colour change which is associated with about a 0.5 unit change in pH. In embodiments, the pH indicator utilised in the device is able to detect the pH between about pH 0 and about pH 14 and indicates changes in pH by way of a colour change along a colour spectrum, with each colour in the spectrum being associated with a particular pH. In embodiments, the pH indicator is able to detect a pH between about pH 5.0 and about pH 10.0. In embodiments, the pH indicator is able to detect a pH between about pH 5.5 and about pH 9.5. More particularly the pH indicator is able to detect a pH between about pH 6.5 and about pH 9.5. Suitable pH indicators include phenylazo compounds such as those listed in Table 1 which are available from Fraunhofer EMFT, Germany.
In some embodiments, the pH indicator is a triarylmethane dye. In some embodiments, the pH indicator is a fluorescent dye.
In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged.
In embodiments, the device is a cellulosic material, for example a cellulose pad. In embodiments, the device is a non-woven mesh or perforated film.
In some embodiments, the fluid is a liquid. Non-limiting examples includes water. In some embodiments, the fluid is a gas, for example for use in a face mask. In some embodiments, the fluid is a moisture. Non-limiting examples include the moisture associated with a soil sample. In some embodiments, the fluid is a bodily sample. Non-limiting examples include, saliva, urine, blood, sweat/perspiration.
In another aspect, a device is provided for determining pH of a fluid sample. The device preferably includes: (a) a fluid-contacting surface, (b) an opposing non-fluid contacting surface, (c) a pH indication zone comprising a pH indicator covalently immobilised therein which indicates the pH of a fluid, wherein the colour of the pH indicator changes in response to a change in the pH of the fluid, and (d) at least one conduit for directing fluid towards the pH indication zone. The conduit helps direct fluid toward the pH indicator without materially altering the pH en route to the indicator. In certain embodiments, the material of the conduit contains no acid or base functionality, that is to say, it is neutral and can not remove any acid or base entities from the fluid until it reaches the pH indicating system. In certain embodiments, the device has an outer surface and the pH indication zone is located at or near the outer surface. In other embodiments, the device has a peripheral edge extending between the fluid contacting surface and the opposing non-fluid contacting surface and pH indication zone is located at or near to this peripheral edge. In certain embodiments, the conduit directs fluid laterally towards the pH indication zone. In embodiments, the pH indicator changes colour in response to change in pH and this colour change is detectable at, for example, intervals of about a 0.1 unit, about 0.2 unit, about 0.3 unit about 0.4 unit or about 0.5 unit interval of pH. It is envisaged that the detection level will vary based on the type of detection means utilised. For example, an electronic detector such as a colour meter has the capability to detect a 0.1 unit change in pH. In comparison, the human eye is only capable of visually detecting a colour change which is associated with about a 0.5 unit change in pH. In embodiments, the pH indicator utilised in the device is able to detect the pH between pH 0 and 14 and indicates changes in pH by way of a colour change along a colour spectrum, with each colour in the spectrum being associated with a particular pH. In embodiments, the pH indicator is able to detect pH between about pH 5 and about pH10. Particularly, the pH indicator is able to detect pH between about pH 5.5 and about pH 9.5. More particularly, the pH indicator is able to detect pH between about pH 6.5 and about pH 9.5. Suitable pH indicators include phenylazo compounds such as those selected from the group listed in Table 1. In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged.
In a further aspect, a formulation is provided for indicating pH of a fluid. Advantageously, the pH indicator is covalently immobilised within the formulation and is therefore not washed away by the fluid upon contact. The formulation preferably includes a dye that functions as a pH indicator. The dye may include a phenylazo compound, where the colour of the phenylazo compound changes in response to a change in the pH of the fluid. In embodiments, the pH dye changes colour in response to a 0.5 unit interval change in pH. For example, the pH indicator has a different colour for each 0.5 unit interval change in pH. The pH indicator utilised in the device is able to detect the pH between pH 5 and 10, particularly between pH 5.5 and 9.5 and more particularly between pH 6.5 and 9.5. Suitable pH indicators include phenylazo compounds such as those selected from the group listed in Table 1. In embodiments, the pH indicator comprises a combination of compounds which allows a broader pH range to be detected than can be detected by use of a single compound. For example, the pH indicator comprises a combination of phenylazo compounds. In embodiments, the combination comprises at least two phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least three phenylazo compounds selected from the group listed in Table 1. In embodiments, the combination comprises at least one phenylazo compound selected from the group listed in Table 1 and at least one compound that is not a phenylazo compound. In embodiments, derivatives or modifications of the phenylazo compounds listed in Table 1 are envisaged. In embodiments, the formulation is applied to a device for use in detecting pH at the point of manufacture. In embodiments, the formulation is an adhesive. In embodiments, the adhesive is a low tack adhesive, for example a silicon adhesive. In other embodiments, it is envisaged that the formulation is a gel, for example, a conformable semi-rigid or rigid gel, that does not disintegrate upon contact with the fluid to be tested. The formulation can be used in a device according to the first and/or second aspect.
In another aspect, a method is provided for monitoring the pH of a fluid. The method preferably comprises the steps of: (a) providing a device comprising a surface configured to contact the fluid, said surface having a pH indicator covalently bound thereto, wherein the pH indicator has a first colour prior to contact with the fluid and changes colour as a function of the pH of the fluid, (b) contacting the device with the fluid, (c) assessing the colour of the pH indicator. It is envisaged that the method can be utilised in numerous applications in which the knowledge of the pH of a fluid sample is paramount to determining quality control or safety. Non-limiting examples of potential applications include: food storage; packaging spoilage indicators; wine; brewing; analysis of drinking water, swimming pool water, river water or fish ponds; agriculture and horticulture; clothing, for example perspiration analysis; in-line monitoring of processes, gases, liquids; skin care—medical (dermatology) or cosmetic; coatings of containers and surfaces to detect changes/inconsistencies; monitoring drug release or stability.
In a further aspect, a device comprises a fluid contacting surface having a pH indicating means covalently bound thereto, wherein the pH indicating means has a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid.
In another aspect a device comprises a pH indicating means, wherein the pH indicating means has a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid and a conduit means for directing the fluid towards the pH indicating means.
Variations and modifications of these embodiments will occur to those of skill in the art after reviewing this disclosure. The foregoing features and aspects may be implemented, in any combination and sub-combinations (including multiple dependent combinations and sub-combinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof, may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.
Further areas of applicability of the disclosed devices and methods will become apparent from the detailed description provided hereinafter. It should be understood that the detailed description and specific examples, while indicating particular embodiments, are intended for purposes of illustration only and are not intended to limit the scope of the disclosure or any of the claims that may be pursued.
The foregoing and other objects and advantages will be appreciated more fully upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference numbers refer to like parts throughout. These depicted embodiments are to be understood as illustrative and not limiting in any way:
To provide an understanding of the devices and methods describe herein, certain illustrative embodiments and examples will now be described.
The device further includes a pH indicator 108 which is applied to one or both of surfaces 102 and/or 104. The pH indicator is covalently immobilised on or adjacent to the surface 102 and/or 104 so that it is not washed away by the fluid.
In embodiments, the pH indicator is chemically bound to the surface 102 and/or 104. For example, the pH indicator is covalently bound directly to the surface 102 and/or 104. In alternative embodiments, the surface 102 and/or 104 is provided within an adhesive and the pH indicator is covalently bound to reactive moieties within the adhesive. For example, a conventional acrylic adhesive, such as K5 (Smith & Nephew, Inc) used in the construction of wound dressings contains residues of 2-hydroxy-ethylmethacrylate, which provide a reactive functional hydroxyl (OH) group, pendant to the polymer backbone, to which the pH indicator can be covalently bound. Other suitable adhesives include acrylic-based adhesives with pendant OH or COOH groups.
In embodiments on which the pH indicator is only applied to one surface of a non-porous device, then an indication, for indicating which side the pH indicator is applied to may be provided. This indication allows the user to appropriately orient the device during placement on or in the fluid to ensure that the surface which has the pH indicator is correctly orientated and comes into contact with the fluid.
The pH indicator may be applied across substantially the entire surface 102 and/or 104, to allow any variations in the pH at the meniscus of the fluid sample to be identified. Alternatively, the pH indicator may be applied to discrete areas of surfaces 102 and/or 104. The pH indicator exhibits a first colour prior to contact with a fluid and changes colour as a function of the pH of the fluid. The first colour of the pH indicator may be colourless.
The pH indicator is capable of reversibly changing colour in response to pH. In embodiments, the pH indicator is a phenylazo compound. In certain embodiments, the phenylazo compound is selected from the group listed in Table 1. In some embodiments, the phenylazo compound is not 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol. In some embodiments, the phenylazo compound is not hydroxy-4-[4[(hydroxyethylsulphonyl)-phenylazo]-napthalene-2-sulphonate. In some embodiments, the phenylazo compound is not 2-fluoro-4-[4[(2-hydroxyethanesulphonyl)-phenylazo]-6-methoxy phenol. In some embodiments, the phenylazo compound is not 4-[4-(2-hydroxyethylsulphonyl)-phenylazo]-2,6-dimethoxyphenol. In certain embodiments, the phenylazo compound is 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol. In some embodiments, the pH indicator includes a plurality of phenylazo compounds. In some embodiments, the pH indicator includes a combination of phenylazo compounds, for example a combination of phenylazo compounds selected from the group listed in Table 1. In some embodiments, the pH indicator includes a combination of two phenylazo compounds. In some embodiments, the pH indicator includes a combination of three phenylazo compounds. In some embodiments, 2-[4(2-hydroxyethylsulfonyl)-phenyl]diazenyl]-4-methylphenol is combined with at least one other phenylazo compound selected from the group listed in Table 1. The ratio of phenylazo compound may be 1:1, but other ratios are envisaged, for example, but in no way limiting, 0.5:1.5 or 1.5:0.5 or 1:2 or 2:1 or 1:0.1. In alternative embodiments, the pH indicator includes at least one phenylazo compound, for example a phenylazo compound selected from the group listed in Table 1 and at least one other compound that is not a phenylazo compound. In certain embodiments, the pH indicator is not a phenylazo compound.
A transparent layer 212 overlays at least part of the pH indication zone, which protects the integrity of the pH indicator but still allows the user to monitor the colour of the pH indicator over time. The device includes at least one conduit that is configured to direct fluid to the pH indication zone 206, ensuring that the pH of the fluid is not materially altered as it passes through the components of the device. One or a plurality of conduits could be used. As shown in
Methods of immobilising a phenylazo dye on the devices illustrated in
In a first step, 25 mg of a phenylazo pH indicating dye, for example a phenylazo pH indicating dye selected from the group listed in Table 1, is reacted with 140 μl concentrated sulphuric acid for 30 mins to form a dye solution.
In a second step, 200 ml of distilled water is added to the dye solution formed in the first step.
In a third step, 406 μl of a 32% w/v solution of sodium hydroxide is added to the solution formed in the second step.
In a fourth step, 25.45 ml of a 2.36M solution of sodium carbonate is added to the solution formed in the third step.
In a fifth step, 1.35 ml of a 32% w/v solution of sodium hydroxide is added to the solution formed in the fourth step and the volume made up to 250 ml with distilled water.
In a sixth step, a material on which the pH indicating dye is to be bound is placed in the solution and left to react for approximately 1-2 hours. Examples of suitable materials include, but are not limited to: TENCEL fibres of the Durafiber product, polyurethane foam of the Allevyn product, cellulose pad of the Opsite Post-op product, or K5 adhesive-coated polyurethane film, all available from Smith & Nephew, Inc. The material is then washed with distilled water until no dye is released. The material is then dried.
A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew, Inc) was prepared in different samples, and each sample was covalently bound with one or a combination of phenylazo dyes, selected from GJM-514, GJM-492, GJM-546, and GJM-534. The structures of these dyes are shown in Table 1. It was discovered that these dyes had colour-changing characteristics that varied according to changes in pH. The Post-Op samples were covalently bound with GJM-514 alone or with GJM-514 combined with one of GJM-492, GJM-546 and GJM-534 using the method as described above in relation to
A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM-514 was exposed to buffered solutions at pH 5 pH 9.5. The panel of photographs in
Table 2 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514 dye over a pH range of pH 5-pH 9.5. An optimal dye for use as a pH indicator is one which demonstrates a linear change in a measurement of a specific parameter of colour (for example L*, a* or b*) over a broad pH range. Outside of the linear region, the dye is either unable to change colour in response to a change in pH or the change in colour is so minimal that it is undetectable.
Taking into account the colour pen results and photographs of the samples, the most accurate working range for GJM514 is between pH 7.5 and pH 9. The linear trend line of the b* measurements has a steeper gradient (−14.34) than the a* measurements (10.94) and therefore b* would be used preferentially to give a more accurate indication of the pH of the dressing when using an optical reader rather than the human eye.
A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM-514:GJM-492 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in
Table 3 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-492 dye combination over a pH range of pH 5-pH 9.5.
Taking into account the colour pen results and photographs of the samples, the working range for this dye combination appears to be between pH 5 and pH 6.5. With a* giving a useable trend line for this region that could be used to estimate the pH from the material colour.
A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM 514:546 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in
Table 4 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-546 dye combination over a pH range of pH 5-pH 9.5.
A sample of the pad from an Opsite. Post-Op dressing (Smith & Nephew) was covalently bound with the dye GJM 514:534 at a 1:1 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in
Table 5 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-534 dye combination over a pH range of pH 5-pH 9.5
A sample of the pad from an Opsite Post-Op dressing (Smith & Nephew) was covalently bound with the dye GM 514:534 at a 1:0.509 ratio was exposed to buffered solutions at pH 5-pH 9.5. The panel of photographs in
Table 6 illustrates the colour pen measurements (L*, a* and b*) of the colour of the GJM-514:GJM-534 dye combination over a pH range of pH 5-pH 9.5
Further to the above general method for preparing covalently bonded dye, different materials were also used unto which to bind the dye.
A sample of a gauze (Kerlix Trademark of Covidiene) and polyvinyl alcohol foam (V.A.C. WhiteFoam, trade mark of KCl) were covalently bound with the dye GJM-546 and 492 in a ratio 1:3.92 as described throughout this disclosure.
These latter materials can be used as pH sensing fillers for Negative Pressure Wound Therapy (NPWT). They were evaluated by use of the following models and experiments.
Materials
Equipment
Method
Use these solutions to adjust horse serum to pH 5 and pH 8, for use in the meat mode.
Determination of the ability of dyed VAC foam and gauze to detect changes in pH of wound fluid.
The pH sensitive gauze and VAC foam were washed after the first meat model experiment and then used in an additional wound model, with pH adjusted water. In addition the extra piece of pH sensitive dyed gauze was placed in a clear Perspex wound model and fluid pumped through.
All wound models were monitored by taking photographs, those carried out in meat could only be monitored from the top surface, but the clear Perspex model could be monitored from all sides.
Results and Discussion
The foam was orange in colour when it was loaded into the wound, but the gauze was more of a red colour. It is believed the gauze is red in colour due to the presence of PHMB on the gauze which would make it basic.
Meat Model 1
The experiment was started by pumping pH 5 horse serum into the wound filler for approximately 2.5 hours before fluid started to appear in the canister and the material started to change colour. After approximately 5.5 hours the pH 5 horse serum solution was changed to pH 8 horse serum and this was run overnight. In the morning the solution was then changed back to pH 5 horse serum and was pumped in for several hours (due to time restrictions the flow rate was increased to 80 μl/min after 3.5 hours).
The images of the pH sensitive dyed gauze changing over time can be seen in
Images of the pH sensitive dyed VAC foam changing over time can be seen in
Meat Model 2
For the second meat model the basic aqueous solution was used first and was left pumping into the model overnight. The next morning the solution was then changed to an acidic aqueous solution and left pumping for several hours.
The images for the pH sensitive gauze can be seen in
The same trend is seen with the dyed VAC foam, as shown in
Clear Perspex Wound Model
The experiment was also carried out using the pH sensitive dyed gauze in a clear Perspex wound model to be able to visualise the colour change throughout the wound. The fluid was not pumped in from the bottom on this occasion but from the left hand side of the wound as seen on the images in
Both the pH sensitive dyed VAC foam and gauze, changed colour as they were exposed to different pH solutions. The colours for indicating the different pH's were clearly visible, and the colour could be reversed by addition of the other pH solution to the wound.
It is to be understood that the foregoing description is merely illustrative and is not to be limited to the details given. While several embodiments have been provided in the present disclosure, it should be understood that the disclosed devices and method and their components, may be embodied in many other specific forms without departing from the scope of the disclosure.
Variations and modifications will occur to those of skill in the art after reviewing this disclosure. The disclosed features may be implemented, in any combination and sub-combinations (including multiple dependent combinations and sub-combinations), with one or more other features described herein. The various features described or illustrated above, including any components thereof may be combined or integrated in other systems. Moreover, certain features may be omitted or not implemented.
Examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the scope of the information disclosed herein. All references cited herein are incorporated by reference in their entirety and made part of this application.
Number | Date | Country | Kind |
---|---|---|---|
1317746.4 | Oct 2013 | GB | national |
This application is a continuation of U.S. application Ser. No. 14/650,547, filed Jun. 8, 2015, which is a 371 of International Application No. PCT/EP2014/071520, filed Oct. 8, 2014, which claims the benefit of United Kingdom Application No. 1317746.4, filed Oct. 8, 2013. The entire contents of the above applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2249867 | Snelling | Jul 1941 | A |
3675654 | Baker et al. | Jul 1972 | A |
3759261 | Wang | Sep 1973 | A |
3896802 | Williams | Jul 1975 | A |
3972328 | Chen | Aug 1976 | A |
4029598 | Neisius et al. | Jun 1977 | A |
4192311 | Felfoldi | Mar 1980 | A |
4705513 | Sheldon et al. | Nov 1987 | A |
4728499 | Fehder | Mar 1988 | A |
4813942 | Alvarez | Mar 1989 | A |
4885077 | Karakelle et al. | Dec 1989 | A |
4999306 | Yafuso et al. | Mar 1991 | A |
5056510 | Gilman | Oct 1991 | A |
5104660 | Chvapil et al. | Apr 1992 | A |
5181905 | Flam | Jan 1993 | A |
5238732 | Krishnan | Aug 1993 | A |
5277872 | Bankert et al. | Jan 1994 | A |
5536783 | Olstein et al. | Jul 1996 | A |
5549584 | Gross | Aug 1996 | A |
5571684 | Lawrence et al. | Nov 1996 | A |
5678448 | Fullen et al. | Oct 1997 | A |
5690610 | Ito et al. | Nov 1997 | A |
5690624 | Sasaki et al. | Nov 1997 | A |
5707499 | Joshi et al. | Jan 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5766212 | Jitoe et al. | Jun 1998 | A |
5788687 | Batich et al. | Aug 1998 | A |
5852126 | Barnard et al. | Dec 1998 | A |
5853669 | Wolfbeis | Dec 1998 | A |
5897516 | Kadash et al. | Apr 1999 | A |
6071267 | Zamierowski | Jun 2000 | A |
6095992 | Augustine | Aug 2000 | A |
6120904 | Hostettler et al. | Sep 2000 | A |
6284942 | Rabin | Sep 2001 | B1 |
6333093 | Burrell et al. | Dec 2001 | B1 |
6381482 | Jayaraman et al. | Apr 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6482491 | Samuelsen et al. | Nov 2002 | B1 |
6517484 | Wilk et al. | Feb 2003 | B1 |
6551252 | Sackner et al. | Apr 2003 | B2 |
6626891 | Ohmstede | Sep 2003 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6688525 | Nelson et al. | Feb 2004 | B1 |
6696240 | Kloepfer et al. | Feb 2004 | B1 |
6731987 | McAdams et al. | May 2004 | B1 |
6747185 | Inoue et al. | Jun 2004 | B2 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6772708 | Klofta et al. | Aug 2004 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7159532 | Klofta et al. | Jan 2007 | B2 |
7201063 | Taylor et al. | Apr 2007 | B2 |
7206623 | Blank et al. | Apr 2007 | B2 |
7216651 | Argenta et al. | May 2007 | B2 |
7316652 | Dalgaard et al. | Jan 2008 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7429255 | Thompson | Sep 2008 | B2 |
7520875 | Bernabei | Apr 2009 | B2 |
7521292 | Rogers et al. | Apr 2009 | B2 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7622629 | Aail | Nov 2009 | B2 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7687678 | Jacobs | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
7749531 | Booher | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7777092 | Lykke et al. | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7811269 | Boynton et al. | Oct 2010 | B2 |
7838717 | Haggstrom et al. | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7873141 | Imai et al. | Jan 2011 | B2 |
7877866 | Greenberg et al. | Feb 2011 | B1 |
7904133 | Gehman et al. | Mar 2011 | B2 |
7910791 | Coffey | Mar 2011 | B2 |
7922703 | Riesinger | Apr 2011 | B2 |
7945302 | McAdams | May 2011 | B2 |
7959624 | Riesinger | Jun 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
8019401 | Smith et al. | Sep 2011 | B1 |
8032210 | Finneran et al. | Oct 2011 | B2 |
8034037 | Adams et al. | Oct 2011 | B2 |
8060174 | Simpson et al. | Nov 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062331 | Zamierowski | Nov 2011 | B2 |
8079247 | Russell et al. | Dec 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8111165 | Ortega et al. | Feb 2012 | B2 |
8116841 | Bly et al. | Feb 2012 | B2 |
8118794 | Weston et al. | Feb 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8207392 | Haggstrom et al. | Jun 2012 | B2 |
8238996 | Burnes | Aug 2012 | B2 |
8241231 | Bausewein et al. | Aug 2012 | B2 |
8241261 | Randolph et al. | Aug 2012 | B2 |
8282611 | Weston | Oct 2012 | B2 |
8303552 | Weston | Nov 2012 | B2 |
8332053 | Patterson et al. | Dec 2012 | B1 |
8333874 | Currie et al. | Dec 2012 | B2 |
8366692 | Weston | Feb 2013 | B2 |
8372049 | Jaeb et al. | Feb 2013 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8425478 | Olson | Apr 2013 | B2 |
8425996 | Gorski et al. | Apr 2013 | B2 |
8444612 | Patel et al. | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8480641 | Jacobs | Jul 2013 | B2 |
8545466 | Andresen et al. | Oct 2013 | B2 |
8568386 | Malhi | Oct 2013 | B2 |
8628505 | Weston | Jan 2014 | B2 |
8641691 | Fink | Feb 2014 | B2 |
8663106 | Stivoric et al. | Mar 2014 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8682442 | McAdams | Mar 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8783948 | Panda et al. | Jul 2014 | B2 |
8788009 | Greene et al. | Jul 2014 | B2 |
8795243 | Weston | Aug 2014 | B2 |
8795257 | Coulthard et al. | Aug 2014 | B2 |
8800386 | Taylor | Aug 2014 | B2 |
8808274 | Hartwell | Aug 2014 | B2 |
8818478 | Scheffler et al. | Aug 2014 | B2 |
8829263 | Haggstrom et al. | Sep 2014 | B2 |
8834451 | Blott et al. | Sep 2014 | B2 |
8894590 | Lamoise et al. | Nov 2014 | B2 |
8925392 | Esposito et al. | Jan 2015 | B2 |
8927801 | Klofta | Jan 2015 | B2 |
8934957 | Dias et al. | Jan 2015 | B2 |
8934965 | Rogers et al. | Jan 2015 | B2 |
8943897 | Beauvais et al. | Feb 2015 | B2 |
8948839 | Longinotti-Buitoni et al. | Feb 2015 | B1 |
8956336 | Haggstrom et al. | Feb 2015 | B2 |
8974428 | Shuler et al. | Mar 2015 | B2 |
8986940 | McNulty et al. | Mar 2015 | B2 |
8997588 | Taylor | Apr 2015 | B2 |
9000251 | Murphy et al. | Apr 2015 | B2 |
9012714 | Fleischmann | Apr 2015 | B2 |
9061095 | Adie et al. | Jun 2015 | B2 |
9127665 | Locke et al. | Sep 2015 | B2 |
9192531 | Wu | Nov 2015 | B2 |
9199012 | Vitaris et al. | Dec 2015 | B2 |
9204806 | Stivoric et al. | Dec 2015 | B2 |
9220455 | Sarrafzadeh et al. | Dec 2015 | B2 |
9220822 | Hartwell et al. | Dec 2015 | B2 |
9226402 | Hsu | Dec 2015 | B2 |
9282897 | Ross, Jr. et al. | Mar 2016 | B2 |
9283118 | Locke et al. | Mar 2016 | B2 |
9302033 | Riesinger | Apr 2016 | B2 |
9311520 | Burg et al. | Apr 2016 | B2 |
9314175 | Jacofsky et al. | Apr 2016 | B2 |
9320473 | Shuler | Apr 2016 | B2 |
9372123 | Li et al. | Jun 2016 | B2 |
9375353 | Vitaris et al. | Jun 2016 | B2 |
9375521 | Hudspeth et al. | Jun 2016 | B2 |
9381283 | Adams et al. | Jul 2016 | B2 |
9402988 | Buchanan et al. | Aug 2016 | B2 |
9408573 | Welch et al. | Aug 2016 | B2 |
9421309 | Robinson et al. | Aug 2016 | B2 |
9427179 | Mestrovic et al. | Aug 2016 | B2 |
9439599 | Thompson et al. | Sep 2016 | B2 |
9445749 | Erickson et al. | Sep 2016 | B2 |
9446178 | Blott et al. | Sep 2016 | B2 |
9494474 | Servati et al. | Nov 2016 | B2 |
9511215 | Skiba | Dec 2016 | B2 |
9516758 | Arora et al. | Dec 2016 | B2 |
9526439 | Connelly et al. | Dec 2016 | B2 |
9554484 | Rogers et al. | Jan 2017 | B2 |
9572507 | Moore et al. | Feb 2017 | B2 |
9582072 | Connor | Feb 2017 | B2 |
9585620 | Paquet et al. | Mar 2017 | B2 |
9587991 | Padiy | Mar 2017 | B2 |
9592007 | Nuovo et al. | Mar 2017 | B2 |
9603560 | Monty et al. | Mar 2017 | B2 |
9613911 | Rogers et al. | Apr 2017 | B2 |
9629584 | Macia Barber et al. | Apr 2017 | B2 |
9629986 | Patel et al. | Apr 2017 | B2 |
9681993 | Wu et al. | Jun 2017 | B2 |
9687195 | Sims et al. | Jun 2017 | B2 |
9829471 | Hammond | Nov 2017 | B2 |
10004643 | Luckemeyer et al. | Jun 2018 | B2 |
20020062114 | Murai et al. | May 2002 | A1 |
20020091347 | Eakin | Jul 2002 | A1 |
20030033032 | Lind et al. | Feb 2003 | A1 |
20030210810 | Gee, Jr. et al. | Nov 2003 | A1 |
20040044299 | Utsugi | Mar 2004 | A1 |
20040133090 | Dostoinov et al. | Jul 2004 | A1 |
20040230132 | Shehada | Nov 2004 | A1 |
20050105789 | Isaacs et al. | May 2005 | A1 |
20050187146 | Helmus et al. | Aug 2005 | A1 |
20050199055 | Browne | Sep 2005 | A1 |
20050280531 | Fadem et al. | Dec 2005 | A1 |
20060009744 | Edrman et al. | Jan 2006 | A1 |
20060140999 | Lendlein et al. | Jun 2006 | A1 |
20070048224 | Howell et al. | Mar 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070129784 | Lendlein et al. | Jun 2007 | A1 |
20070142762 | Kaplan et al. | Jun 2007 | A1 |
20070173892 | Fleischer et al. | Jul 2007 | A1 |
20070188759 | Mehendale et al. | Aug 2007 | A1 |
20070191754 | Aali | Aug 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070270774 | Bergman et al. | Nov 2007 | A1 |
20070276207 | Eagland et al. | Nov 2007 | A1 |
20080132821 | Propp et al. | Jun 2008 | A1 |
20080167535 | Stivoric et al. | Jul 2008 | A1 |
20080208151 | Zacharias et al. | Aug 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20080319283 | Cotton et al. | Dec 2008 | A1 |
20090062757 | Long et al. | Mar 2009 | A1 |
20090125004 | Shen et al. | May 2009 | A1 |
20090157024 | Song | Jun 2009 | A1 |
20090190135 | Clarizia et al. | Jul 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090245601 | Cohen et al. | Oct 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299306 | Buan | Dec 2009 | A1 |
20100022990 | Karpowicz et al. | Jan 2010 | A1 |
20100025831 | Yamazaki et al. | Feb 2010 | A1 |
20100041968 | Meschisen et al. | Feb 2010 | A1 |
20100112680 | Brockwell et al. | May 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100166252 | Ahmed et al. | Jul 2010 | A1 |
20100168695 | Robles et al. | Jul 2010 | A1 |
20100168700 | Schmidt et al. | Jul 2010 | A1 |
20100168727 | Hancock et al. | Jul 2010 | A1 |
20100178203 | Kane et al. | Jul 2010 | A1 |
20100268111 | Drinan et al. | Oct 2010 | A1 |
20100305473 | Yuzhakov | Dec 2010 | A1 |
20100318052 | Ha et al. | Dec 2010 | A1 |
20110004088 | Grossman | Jan 2011 | A1 |
20110004172 | Eckstein et al. | Jan 2011 | A1 |
20110054283 | Shuler | Mar 2011 | A1 |
20110092958 | Jacobs | Apr 2011 | A1 |
20110118683 | Weston | May 2011 | A1 |
20110218757 | Callsen et al. | Sep 2011 | A1 |
20110224631 | Simmons | Sep 2011 | A1 |
20110245682 | Robinson et al. | Oct 2011 | A1 |
20110274593 | Gorski et al. | Nov 2011 | A1 |
20110301441 | Bandic et al. | Dec 2011 | A1 |
20120029306 | Paquet et al. | Feb 2012 | A1 |
20120029307 | Paquet et al. | Feb 2012 | A1 |
20120029410 | Koenig et al. | Feb 2012 | A1 |
20120095380 | Gergley et al. | Apr 2012 | A1 |
20120165717 | Al Khaburi et al. | Jun 2012 | A1 |
20120190956 | Connolly | Jul 2012 | A1 |
20120190989 | Kaiser et al. | Jul 2012 | A1 |
20120201437 | Ohnemus | Aug 2012 | A1 |
20120215190 | Kawashima | Aug 2012 | A1 |
20120256750 | Novak | Oct 2012 | A1 |
20120264163 | Booher | Oct 2012 | A1 |
20120271265 | Langdon | Oct 2012 | A1 |
20120277559 | Kohl-Bareis et al. | Nov 2012 | A1 |
20120279101 | Pretsch et al. | Nov 2012 | A1 |
20120316538 | Heiser et al. | Dec 2012 | A1 |
20120323274 | Lendlein et al. | Dec 2012 | A1 |
20130041235 | Rogers et al. | Feb 2013 | A1 |
20130064772 | Swiss et al. | Mar 2013 | A1 |
20130066285 | Locke et al. | Mar 2013 | A1 |
20130066289 | Song et al. | Mar 2013 | A1 |
20130087298 | Phillips et al. | Apr 2013 | A1 |
20130090616 | Neubauer | Apr 2013 | A1 |
20130121544 | Sarrafzadeh et al. | May 2013 | A1 |
20130131621 | Van Holten et al. | May 2013 | A1 |
20130138054 | Fleischmann | May 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130151223 | Zamierowski et al. | Jun 2013 | A1 |
20130165878 | Heagle | Jun 2013 | A1 |
20130200268 | Rafferty et al. | Aug 2013 | A1 |
20130261409 | Pathak et al. | Oct 2013 | A1 |
20130274629 | Duesterhoft et al. | Oct 2013 | A1 |
20130274688 | Weston | Oct 2013 | A1 |
20130303865 | Rebec et al. | Nov 2013 | A1 |
20130317367 | Shuler | Nov 2013 | A1 |
20140031663 | Gallego et al. | Jan 2014 | A1 |
20140072190 | Wu et al. | Mar 2014 | A1 |
20140098209 | Neff | Apr 2014 | A1 |
20140107495 | Marinelli et al. | Apr 2014 | A1 |
20140114268 | Auguste et al. | Apr 2014 | A1 |
20140121487 | Faybishenko et al. | May 2014 | A1 |
20140138441 | Davalos et al. | May 2014 | A1 |
20140147611 | Ackerman, Jr. et al. | May 2014 | A1 |
20140154789 | Polwart et al. | Jun 2014 | A1 |
20140203797 | Stivoric et al. | Jul 2014 | A1 |
20140206947 | Isserow et al. | Jul 2014 | A1 |
20140228791 | Hartwell | Aug 2014 | A1 |
20140232516 | Stivoric et al. | Aug 2014 | A1 |
20140243709 | Gibson et al. | Aug 2014 | A1 |
20140296749 | Reid, Jr. et al. | Oct 2014 | A1 |
20140296808 | Curran et al. | Oct 2014 | A1 |
20140298927 | Allin et al. | Oct 2014 | A1 |
20140316359 | Collinson et al. | Oct 2014 | A1 |
20140340857 | Hsu et al. | Nov 2014 | A1 |
20140350882 | Everett et al. | Nov 2014 | A1 |
20150025343 | Gareau et al. | Jan 2015 | A1 |
20150032035 | Banwell et al. | Jan 2015 | A1 |
20150055134 | Papautsky et al. | Feb 2015 | A1 |
20150065965 | Haggstrom et al. | Mar 2015 | A1 |
20150080685 | Markle et al. | Mar 2015 | A1 |
20150138330 | Krishnamoorthi | May 2015 | A1 |
20150141767 | Rogers et al. | May 2015 | A1 |
20150182166 | Evans et al. | Jul 2015 | A1 |
20150223716 | Korkala et al. | Aug 2015 | A1 |
20150257644 | Cao | Sep 2015 | A1 |
20150265743 | Hanson et al. | Sep 2015 | A1 |
20150292968 | Vogt et al. | Oct 2015 | A1 |
20150313476 | Pisani et al. | Nov 2015 | A1 |
20150313533 | Rapp et al. | Nov 2015 | A1 |
20150327777 | Kostic et al. | Nov 2015 | A1 |
20150335254 | Fastert et al. | Nov 2015 | A1 |
20150335288 | Toth et al. | Nov 2015 | A1 |
20150351970 | Dagger et al. | Dec 2015 | A1 |
20150359485 | Berg et al. | Dec 2015 | A1 |
20160015962 | Shokoueinejad Maragheh | Jan 2016 | A1 |
20160022223 | Grundfest et al. | Jan 2016 | A1 |
20160029900 | LaPlante et al. | Feb 2016 | A1 |
20160038064 | Johnson | Feb 2016 | A1 |
20160038083 | Ding et al. | Feb 2016 | A1 |
20160058380 | Lee et al. | Mar 2016 | A1 |
20160066854 | Mei et al. | Mar 2016 | A1 |
20160069743 | McQuilkin et al. | Mar 2016 | A1 |
20160074234 | Abichandi et al. | Mar 2016 | A1 |
20160081580 | Bergelin et al. | Mar 2016 | A1 |
20160100790 | Cantu et al. | Apr 2016 | A1 |
20160100987 | Hartwell et al. | Apr 2016 | A1 |
20160101282 | Bergelin et al. | Apr 2016 | A1 |
20160144084 | Collinson et al. | May 2016 | A1 |
20160232807 | Ghaffari et al. | Aug 2016 | A1 |
20160249810 | Darty et al. | Sep 2016 | A1 |
20160262672 | Hammond et al. | Sep 2016 | A1 |
20160262687 | Vaidyanathan et al. | Sep 2016 | A1 |
20160287177 | Huppert et al. | Oct 2016 | A1 |
20160298620 | Cordoba et al. | Oct 2016 | A1 |
20160302729 | Starr et al. | Oct 2016 | A1 |
20160354001 | Buckley et al. | Dec 2016 | A1 |
20160367189 | Aimone et al. | Dec 2016 | A1 |
20160367406 | Barnett | Dec 2016 | A1 |
20170000407 | Saxby et al. | Jan 2017 | A1 |
20170027498 | Larson et al. | Feb 2017 | A1 |
20170079740 | Hufnagel et al. | Mar 2017 | A1 |
20170086519 | Vigano et al. | Mar 2017 | A1 |
20170086709 | Khine et al. | Mar 2017 | A1 |
20170095208 | Oberleitner et al. | Apr 2017 | A1 |
20170161893 | Carnes et al. | Jun 2017 | A1 |
20170164865 | Rafferty et al. | Jun 2017 | A1 |
20170164876 | Hyde et al. | Jun 2017 | A1 |
20170172439 | Zhu et al. | Jun 2017 | A1 |
20170183705 | Hicks et al. | Jun 2017 | A1 |
20170234802 | Hicks et al. | Aug 2017 | A1 |
20180008177 | Shimuta et al. | Jan 2018 | A1 |
Number | Date | Country |
---|---|---|
2003204827 | May 2006 | AU |
101490556 | Jul 2009 | CN |
201414880 | Mar 2010 | CN |
103217503 | Jul 2013 | CN |
105395184 | Mar 2016 | CN |
34 43 101 | May 1986 | DE |
20 2004 017 052 | Jul 2005 | DE |
0 257 916 | Mar 1988 | EP |
0 340 018 | Nov 1989 | EP |
0 430 608 | Jun 1991 | EP |
1 476 217 | Mar 2008 | EP |
2 021 046 | Mar 2012 | EP |
2 454 990 | May 2012 | EP |
2 462 908 | Jun 2012 | EP |
2 574 275 | Apr 2013 | EP |
1 854 342 | Jun 2014 | EP |
1 734 858 | Jul 2014 | EP |
2 544 642 | Jan 2015 | EP |
2 648 668 | Jan 2015 | EP |
2 451 349 | Apr 2016 | EP |
2 941 195 | Dec 2016 | EP |
1 163 907 | Oct 1958 | FR |
905040 | Sep 1962 | GB |
1255395 | Dec 1971 | GB |
S54-176283 | Dec 1979 | JP |
S57-162304 | Oct 1982 | JP |
H07-055788 | Mar 1995 | JP |
2002-165757 | Jun 2002 | JP |
2006-338521 | Dec 2006 | JP |
2007-163350 | Jun 2007 | JP |
2012-157438 | Aug 2012 | JP |
20120059006 | Jun 2012 | KR |
114854 | Apr 2012 | RU |
WO 198300742 | Mar 1983 | WO |
WO 1995029959 | Nov 1995 | WO |
WO 199605873 | Feb 1996 | WO |
WO 199812996 | Apr 1998 | WO |
WO 199912581 | Mar 1999 | WO |
WO 2002047737 | Jun 2002 | WO |
WO 2005025447 | Mar 2005 | WO |
WO 2005052572 | Jun 2005 | WO |
WO 2005123170 | Dec 2005 | WO |
WO 2006052839 | May 2006 | WO |
WO 2006110502 | Oct 2006 | WO |
WO 2006133430 | Dec 2006 | WO |
WO 2007030379 | Mar 2007 | WO |
WO 2008003920 | Jan 2008 | WO |
WO 2008006150 | Jan 2008 | WO |
WO 2008010604 | Jan 2008 | WO |
WO 2008125995 | Oct 2008 | WO |
WO 2009066105 | May 2009 | WO |
WO 2009124100 | Oct 2009 | WO |
WO 2009141777 | Nov 2009 | WO |
WO 2009158128 | Dec 2009 | WO |
WO 2010020919 | Feb 2010 | WO |
WO 2010105053 | Sep 2010 | WO |
WO 2010142959 | Dec 2010 | WO |
WO 2011098575 | Aug 2011 | WO |
WO 2011135285 | Nov 2011 | WO |
WO 2011135286 | Nov 2011 | WO |
WO 2011135287 | Nov 2011 | WO |
WO 2011144888 | Nov 2011 | WO |
WO 2012074509 | Jun 2012 | WO |
WO 2012131237 | Oct 2012 | WO |
WO 2012131386 | Oct 2012 | WO |
WO 2012140378 | Oct 2012 | WO |
WO 2012143665 | Oct 2012 | WO |
WO 2013010907 | Jan 2013 | WO |
WO 2013026999 | Feb 2013 | WO |
WO 2013044226 | Mar 2013 | WO |
WO 2013074509 | May 2013 | WO |
WO 2013083800 | Jun 2013 | WO |
WO 2013090810 | Jun 2013 | WO |
WO 2013136181 | Sep 2013 | WO |
WO 2013149078 | Oct 2013 | WO |
WO 2014008348 | Jan 2014 | WO |
WO 2014016759 | Jan 2014 | WO |
WO 2014020440 | Feb 2014 | WO |
WO 2014020443 | Feb 2014 | WO |
WO 2014066913 | May 2014 | WO |
WO 2014108476 | Jul 2014 | WO |
WO 2014113253 | Jul 2014 | WO |
WO 2014113770 | Jul 2014 | WO |
WO 2015022334 | Feb 2015 | WO |
WO 2015022340 | Feb 2015 | WO |
WO 2015031216 | Mar 2015 | WO |
WO 2015052225 | Apr 2015 | WO |
WO 2015112095 | Jul 2015 | WO |
WO 2015168720 | Nov 2015 | WO |
WO 2016005288 | Jan 2016 | WO |
WO 2016012219 | Jan 2016 | WO |
WO 2016025438 | Feb 2016 | WO |
WO 2016030752 | Mar 2016 | WO |
Entry |
---|
International Search Report, re PCT Application No. PCT/EP2014/071510, dated Feb. 5, 2015. |
International Preliminary Report for Patentability, re PCT Application No. PCT/EP2014/071510, dated Apr. 21, 2016. |
International Search Report and Written Opinion, re PCT Application No. PCT/EP2014/071520, dated Feb. 5, 2015. |
International Preliminary Report for Patentability, re PCT Application No. PCT/EP2014/071520, dated Apr. 21, 2016. |
Kendall ULTEC Hydrocolloid Dressing (4″×4″), product ordering page, web page downloaded Jul. 13, 2014. |
Loh, B.Y. et al., “Automated Mobile pH Reader on a Camera Phone”, IAENG International Journal of Computer Science, vol. 38(3), Aug. 2011, in 7 pages. |
Advantec MFS, Inc., “Membrane Filters” (catalog), accessed Jan. 29, 2016 (publication date unknown, but believed to be copyright 2001-2011), in 17 pages. URL: http://www.advantecmfs.com/catalog/filt/membrane.pdf#page=11. |
Protz, Kerstin: “Moderne Wundauflagen unterstutzen Heilungsprozess”, Wundversorgung: Indikation und Anwendung, Geriatrie Journal, Apr. 2005, pp. 3333-3339, with translation. |
Raviglione, A. et al., “Real-Time Smart Textile-Based System to Monitor Pressure Offloading of Diabetic Foot Ulcers”, Journal of Diabetes Science and Technology, vol. 11, Sep. 2017, in 5 pages. |
Smith & Nephew, “PICO Single Use Negative Pressure Wound Therapy System”, spiral booklet, Mar. 2011, in 7 pages. |
Trupp, S., “Developemt of pH-sensitive indicator dyes for the preparation of micro-patterned optical sensor layers”, Sensors and Actuators B, vol. 150, Jul. 15, 2010, pp. 206-210, in 5 pages. |
Aubakir, B. et al., “Vital Sign Monitoring Utilizing Eulerian Video Magnification and Thermography”, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 16, 2016, pp. 3527-3530, in 4 pages. |
Chen, C. et al., “A PNIPAM-based fluorescent nanothermometer with ratiometric readout”, Chemical Communications, vol. 47, No. 3, Nov. 26, 2010, in 3 pages. |
Dargaville, T. et al., “Sensors and imaging for wound healing: A review,” Biosensors and Bioelectronics, vol. 41, Mar. 2013, pp. 30-42, in 13 pages. |
Farooqui, M. et al., “Low Cost Inkjet Printed Smart Bandage for Wireless Monitoring of Chronic Wounds”, Scientific Reports, vol. 6, Jun. 29, 2016, in 14 pages. |
McLeod, A. et al., “Motion Magnification for Endoscopic Surgery”, Progress in Biomedical Optics and Imaging, SPIE—International Society for Optical Engineering, Mar. 12, 2014, vol. 9036, in 8 pages. |
Mohr, G. et al., “Design of acidochromic dyes for facile preparation of pH sensor layers”, Anal Bioanal Chem, vol. 392, pp. 1411-1418, in 8 pages. |
Reddy, T. et al., “Synthesis and Characterization of Semi-Interpenetrating Polymer Networks Based on Polyurethane and N-isopropylacrylamide for Wound Dressing”, Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 88B, No. 1, Sep. 8, 2008, in 9 pages. |
Uchiyama, S. et al., “Fluorescent molecular thermometers based on polymers showing temperature-induced phase transitions and labeled with polarity-responsive benzofurazans”, Analytical Chemistry, Amercial Chemical Society, vol. 75, No. 21, Oct. 4, 2003, in 10 pages. |
Number | Date | Country | |
---|---|---|---|
20180196021 A1 | Jul 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14650547 | US | |
Child | 15804748 | US |